Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases
- 17 July 2003
- Vol. 327 (7407), 147-149
- https://doi.org/10.1136/bmj.327.7407.147
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Estimation of glomerular filtration rate to prevent life-threatening hyperkalemia due to combined therapy with spironolactone and angiotensin-converting enzyme inhibition or angiotensin receptor blockadeThe American Journal of Cardiology, 2002
- Hyperkalemia in congestive heart failure patients aged 63 to 85 years with subclinical renal diseaseThe American Journal of Cardiology, 2002
- Life-Threatening Hyperkalemia: A Complication of Spironolactone for Heart Failure in a Patient with Renal InsufficiencyAnesthesia & Analgesia, 2002
- Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 casesAmerican Journal Of Medicine, 2001
- Serious adverse events experienced by patients with chronic heart failure taking spironolactoneHeart, 2001
- Striking Increase of Natriuresis by Low-Dose Spironolactone in Congestive Heart Failure Only in Combination With ACE InhibitionCirculation, 2000
- Elderly heart failure patients with drug-induced serious hyperkalemiaAging Clinical and Experimental Research, 2000
- Spironolactone and congestive heart-failureThe Lancet, 2000
- ABC of heart failure: Acute and chronic management strategiesBMJ, 2000
- Diuretic complications.2000